In The News Posted March 3, 2019 Share Posted March 3, 2019 SHENYANG, China, March 3, 2019 /PRNewswire/ -- 3SBio Inc. ("3SBio") (HKEX: 1530) and Taiwan Liposome Company, Ltd. ("TLC") (Nasdaq: TLC, TWO: 4152) today announced an exclusive partnership to commercialize in mainland China two liposomal products utilizing TLC's proprietary NanoX™... View the full article Link to comment Share on other sites More sharing options...
Recommended Posts
Archived
This topic is now archived and is closed to further replies.